Commission Selects Six Future and Emerging Technologies (FET) Projects to Compete for Research Funding

Six research projects selected to compete for two top spots in the area of research into future and emerging technologies (FET) have been announced by the European Commission at the FET11 conference and exhibition in Budapest. The six contenders will receive around €1.5 million each to refine their proposal for one year, after which only two will be selected. The aim of these flagship initiatives will be to deliver major breakthroughs in information and communication technologies (ICT), with the potential to provide solutions to some of society's biggest challenges. The two initiatives selected for long-term funding will run for 10 years, each with a total budget of up to €100 million per year.

Neelie Kroes, European Commission Vice-President for the Digital Agenda, said: "The finalists announced today will plant the seeds for tomorrow's innovation. Europe hosts some of the world's leading researchers in the fascinating and highly inspiring area of future and emerging technologies. By joining forces to address grand challenges, European, national and regional funding can lead to innovations that will tackle problems like neuro-degenerative diseases and climate change."

The finalists are (in alphabetical order):

  • FuturICT Knowledge Accelerator and Crisis-Relief System: ICT can analyse vast amounts of data and complex situations so as to better predict natural disasters, or manage and respond to man-made disasters that cross national borders or continents.
  • Graphene Science and technology for ICT and beyond: Graphene is a new substance developed by atomic and molecular scale manipulation that could replace silicon as the wonder material of the 21st century.
  • Guardian Angels for a Smarter Life: tiny devices without batteries that act like autonomous personal assistants, and which can sense, compute and communicate potentially even while travelling through your bloodstream.
  • The Human Brain Project: understanding the way in which the human brain works can bring the benefits of brain-related or brain-inspired developments to computing architectures, neuroscience and medicine.
  • IT Future of Medicine: digital technology has the power to deliver individualised medicine, based on molecular, physiological and anatomical data collected from individual patients and processed on the basis of globally integrated medical knowledge.
  • Robot Companions for Citizens: soft skinned and intelligent robots have highly developed perceptive, cognitive and emotional skills, and can help people, radically hanging the way humans interact with machines.

To break new ground, FET Flagship contenders will have to look beyond traditional ICT research and link up with specialists in other fields like health-, material- and neuro-sciences and neuro-robotics.

Successfully tackling such fundamental research challenges will only be possible through the combined efforts of top scientists from all over Europe. Most of the proposals announced today are backed by many companies and research funding agencies and hundreds of scientists.

They will also need the combined resources of the EU's Research Framework Programme, national and regional research programmes and industry. By comparison, an earlier initiative to fully map the human genome involved hundreds of scientists across the globe and cost more than US$ 3 billion (roughly €2.1 billion) over 13 years. FET flagship projects face similarly huge challenges, with equally impressive potential benefits.

Flagship competition: In 2010 the Commission invited Europe's scientists to identify challenges and propose projects. From the 21 proposals received, an expert panel selected the six initiatives with the strongest potential for realising scientific breakthroughs, and with the greatest impact on Europe's social and industrial challenges.

Future and Emerging Technologies (FET): FET is the incubator and pathfinder for new ideas and themes for long-term research in information and communication technologies (ICT).The programme is managed by the Commission's Information Society & Media Directorate-General. FET's mission is to go beyond the conventional boundaries of ICT and venture into uncharted areas, increasingly relying on collaboration with different scientific disciplines (like biology, chemistry, nanoscience, neuro- and cognitive science, ethnology, social science, economics) the arts and humanities.

The Future and Emerging Technologies programme began in 1989. Three recent Nobel Prize-winners, Theodor Hänsch, Albert Fert and Peter Grünberg, were all involved in FET-funded research projects.

FET is funded under the EU's Seventh Framework Programme (FP7). The European Commission is increasing the FP7 budget for FET research by 20% per year up from €100 million today, and Member States are invited to match this effort with similar increases. The Commission funds FET research with a total budget of €500 million for 2010-2013.

Cutting edge Future and Emerging Technologies are currently in the spotlight at FET 11 in Budapest (www.fet11.eu). This conference and exhibition on visionary, high risk and long-term research in information science and technology will seed new ideas across disciplines that will reshape the future.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...